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Abstract
Background: Exposure to particulate matter (PM) is associated with increased incidence of cardiovascular disease
and increased coagulation, but the molecular mechanisms underlying these associations remain unknown. Obesity
may increase susceptibility to the adverse effects of PM exposure, exacerbating the effects on cardiovascular
diseases. Extracellular vesicles (EVs), which travel in body fluids and transfer microRNAs (miRNAs) between tissues,
might play an important role in PM-induced cardiovascular risk. We sought to determine whether the levels of PM
with an aerodynamic diameter ≤ 10 μm (PM10) are associated with changes in fibrinogen levels, EV release, and the
miRNA content of EVs (EV-miRNAs), investigating 1630 overweight/obese subjects from the SPHERE Study.
Results: Short-term exposure to PM10 (Day before blood drawing) was associated with an increased release of EVs
quantified by nanoparticle tracking analysis, especially EVs derived from monocyte/macrophage components (CD14
+) and platelets (CD61+) which were characterized by flow cytometry. We first profiled miRNAs of 883 subjects by
the QuantStudio™ 12 K Flex Real Time PCR System and the top 40 EV-miRNAs were validated through custom
miRNA plates. Nine EV-miRNAs (let-7c-5p; miR-106a-5p; miR-143-3p; miR-185-5p; miR-218-5p; miR-331-3p; miR-642-
5p; miR-652-3p; miR-99b-5p) were downregulated in response to PM10 exposure and exhibited putative roles in
cardiovascular disease, as highlighted by integrated network analysis. PM10 exposure was significantly associated
with elevated fibrinogen levels, and five of the nine downregulated EV-miRNAs were mediators between PM10
exposure and fibrinogen levels.
Conclusions: Research on EVs opens a new path to the investigation of the adverse health effects of air pollution
exposure. EVs have the potential to act both as markers of PM susceptibility and as potential molecular mechanism
in the chain of events connecting PM exposure to increased coagulation, which is frequently linked to exposure
and CVD development.
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Background
According to the World Health Organization, air pollu-
tion poses a severe risk to cardiovascular (CV) health,
with ~3% of cardiopulmonary deaths each year being at-
tributable to particulate matter (PM) globally [1]. Acute
or chronic PM exposure can trigger myocardial ischemia
(MI), stroke, and arrhythmia, particularly in at-risk pop-
ulations [2, 3].
Obesity is a strong risk factor for cardiovascular dis-
ease (CVD). Recent research findings identified obesity
as a susceptibility factor to the adverse effects of PM ex-
posure, due in part to increased particle deposition in
the lower airways [4]. Obesity modifies the effects of PM
exposure on heart rate variability and markers of inflam-
mation, oxidative stress, and acute phase response [5–7].
However, the mechanisms linking PM exposure to CVD
development have not been fully elucidated.
Ambient particles produce a strong inflammatory re-
action in the lungs, but only a very small fraction of
these particles accumulate in extrapulmonary organs,
such as liver or spleen [8]. Currently, there is no conclu-
sive evidence that PM physically enter and deposit in
blood vessels, although a recent paper by Miller et al.
showed a translocation of inhaled gold nanoparticles
(<10 nm) into the systemic circulation and accumulation
at sites of vascular inflammation, in healthy volunteers [9].
In this context, a cross-talk between the pulmonary and
CV systems may underlie the observed peripheral effects
of PM exposure [10]. Besides direct cell-cell contact and
communication mediated by nonspecific soluble factors,
cells communicate through extracellular membrane vesi-
cles that are released in all body fluids. The importance of
these extracellular vesicles (EVs) lies in their capacity to
transfer specific information to other cells, thereby influ-
encing recipient cell function [10].
EV cargo includes microRNAs (miRNAs): small, endogen-
ous, single-stranded noncoding RNAs of 20–22 nucleotides
that post-transcriptionally regulate gene expression by trig-
gering mRNA cleavage or repressing translation [11]. EVs
and EV-associated miRNAs (EV-miRNAs) might be ideal
candidates for mediators of the CV effects of PM exposure.
Specifically, EVs could be produced by the respiratory
system [12], reach the systemic circulation, and trans-
fer miRNAs [13] to recipient cells as the EVs travel
throughout the body. These miRNAs could modulate
target gene expression in recipient cells, thereby lead-
ing to CV dysfunction [14].
In the present study, we investigated the effects of ex-
posure to PM with an aerodynamic diameter ≤ 10 μm
(PM10) on the release and miRNA content of EVs in
plasma from overweight/obese individuals [15]. We pro-
filed miRNAs whose levels were altered in response to
PM10 and estimated the proportion of PM10 effects on fi-
brinogen [16] that were mediated by differential miRNA
expression. Bioinformatics analysis was used to investigate
the putative mechanisms of action of the differentially
expressed EV-miRNAs.
Methods
Study design and participants
Overweight/obese subjects were recruited at the Center
for Obesity and Work (COW; Department of Preventive
Medicine, IRCCS Fondazione Ca’Granda – Ospedale
Maggiore Policlinico, Milan, Italy) between September
2010 and March 2015, as part of the cross-sectional
study SPHERE.
(“Susceptibility to Particle Health Effects, miRNAs and
Exosomes”). The study design and subject recruitment
criteria have been extensively described in (16). Briefly,
the eligibility criteria for participants are: 1) older than
18 years at enrollment; 2) obese/overweight according to
the following definition: overweight is defined as a BMI
between 25 and 30 kg/cm2, obesity is defined as a BMI
of 30 kg/cm2 or more; 3) resident in Lombardy at the
time of the recruitment; 4) agreement to sign an informed
consent and donate blood and urine samples. Exclusion
criteria include: previous diagnosis of cancer, heart disease
or stroke in the last year or other chronic diseases such as
multiple sclerosis, Alzheimer’s disease, Parkinson’s disease,
depression, bipolar disorder, schizophrenia and epilepsy.
Each participant signed an informed consent form,
which had been approved by the ethics committee of the
institution (approval number 1425), in accordance with
principles of the Helsinki Declaration. The participation
rate of the overall recruitment was 92%. Body mass
index (BMI) was calculated and categorized according to
the current definition. [17] We followed a two-stage,
split-sample study design for miRNA analysis. A diagram
describing the study design is reported in Additional file 1.
Quantitative determination of fibrinogen in citrate
plasma samples was obtained on automated I.L. Coagu-
lation System (Instrumentation Laboratory S.p.A. Milan,
Italy).
PM exposure assessment
Under the hypothesis that a short-term mechanism un-
derlies variations in EV and EV-miRNA levels, we chose
to investigate a 1-week lag exposure time window before
the day of recruitment (defined as Day −1). We collected
daily PM10 data from the available fixed monitoring stations
of the Air Quality Monitoring Network of the Regional En-
vironmental Protection Agency (ARPA Lombardia). PM10
exposure data for years 2010–2012 were assessed by the
ARPA chemical transport model (CTM) [18], which pro-
vided daily PM10 concentration estimates with a spatial
resolution of 4 × 4 km. Using ArcGIS® software (Esri), we
assigned to each subject the daily PM10 concentration from:
(1) the nearest monitor to their home address (“subject
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residence”) for the 7 days preceding recruitment; (2) the
nearest monitor to the COW (defined as “Policlinico”) for
the day of recruitment; and (3) the 4 × 4 km cell of the
CTM grid containing the subject’s residence.
Meteorological data were obtained from ARPA moni-
toring stations, which measured temperature (233 mon-
itors) and relative humidity (163 monitors). Apparent
temperature was calculated as previously reported [19].
Detailed explanation of the exposure assessment
methods is reported elsewhere [20].
Isolation and purification of EVs and miRNA-EVs from
plasma
Blood was collected into EDTA tubes at the COW on
the morning of recruitment (8 to 10 a.m.) and trans-
ported to the EPIGET Lab (University of Milan) within
2 h of phlebotomy. Isolation, extraction, and purification
of EVs and EV-miRNAs from plasma were performed as
described in the Additional file 2.-Supplemental Methods
S1. For quality control, purified EVs were analyzed by
transmission electron microscopy, following standard
preparation protocols [21]. Examples of purified EV prep-
arations are reported in Additional file 3.
Nanoparticle tracking analysis (NTA)
Numbers and dimensions of EVs were assessed by NTA,
a technique that measures the Brownian motion of vesi-
cles suspended in fluid and displays them in real time
through a CCD camera with high sensitivity. Using a
NanoSight LM10-HS system (Amesbury, UK), EVs were
visualized by laser light scattering. Five 30-s recordings
were made for each sample. Collected data were analyzed
with NTA software, which provided high-resolution
particle-size distribution profiles and concentration
measurements of the EVs.
Flow cytometry
EVs were characterized by flow cytometry (MACS-
Quant, Miltenyi Biotec) according to a protocol for
characterization of EVs [22]. Fluoresbrite® Carboxylate
Size Range Kit I (0.2, 0.5, 0.75, and 1 μm) was used to
set the calibration gate on the analyzer. EVs were
stained before analysis as described in the Additional
file 2- Supplemental Methods S2. Quantitative multipa-
rameter analysis of flow cytometry data was carried out
by using FlowJo Software (Tree Star, Inc.).
Screening of miRNA expression
MiRNAs were prepared by standard reverse transcription
(RT) and preamplification procedures (see Additional
file 2- Supplemental Methods S3), followed by real-time
RT-PCR analysis with the QuantStudio™ 12 K Flex
OpenArray® Platform (QS12KFlex). Gene Expression
Suite Software (Life Technologies) was used to process
miRNA expression data from the miRNA panel.
We obtained 758 Crt values for each subject, which in-
cluded 754 unique miRNAs and four internal controls
(ath-miR159a, RNU48, RNU44 and U6). For each ampli-
fication curve, we obtained an AmpScore value, a quality
measurement that indicates the low signal in the amplifi-
cation curve linear phase (range: 0–2). MiRNAs with Crt
value > 28 or AmpScore <1.1 or missing were considered
unamplified, and the Crt value was set to 29. MiRNAs that
were not amplified in all subjects (n = 209) were excluded,
resulting in 545 miRNAs being included in the analysis.
NormFinder [23] and geNorm [24] algorithms were used
to select the best normalization strategy among global
mean, RNU48, RNU6, or the average of the four miRNAs
with the lowest standard deviation (SD) among subjects
(hsa-miR-526b-5p, hsa-miR-186-5p, hsa-miR-496, and
hsa-miR-541-3p). Global mean was selected as the best
normalization method. MiRNA expression was deter-
mined using the relative quantification 2-ΔCrt [25].
Validation of miRNA expression
We identified the top 40 miRNAs that were the most
associated with PM10 exposure on the day before re-
cruitment and were expressed in at least 50% of sub-
jects. These miRNAs were validated in triplicate by
using similar preamplification, loading, and analyzing
conditions as the screening phase, with minor modifica-
tions (see Additional file 2- Supplemental Methods S4).
Statistical analysis
Quantitative data were expressed as the mean ± SD or
as the median and interquartile range (Q1-Q3) as appro-
priate. Categorical data were presented as frequencies
and percentages. Continuous variables were tested for
normality and linearity. All multivariable models were
adjusted for some a priori covariates: age, sex, BMI, smok-
ing habits, regardless of the p value returned by respective
univariate models. Other variables, such as apparent
temperature, season of enrollment, education, occupation,
alcohol consumption, blood pressure, heart rate, uric acid,
cholesterol, triglyceride, creatinine, glycaemia, homo-
cysteine, glycated hemoglobin, insulin, were additionally
considered as possible confounders, but only apparent
temperature at Day −1 resulted significantly associated
with the outcomes and was therefore added into the
models. Multiple linear regression analysis was used to
evaluate the association between EVs (number and
characterization) and PM exposure. EV counts and
characterizations showed skewed distributions and
were naturally log-transformed to approximately nor-
mal distributions of residuals. Effects were expressed
as Δ%, which represents the percentage increase in
EVs for each 10-μg/m3 increase in PM10 concentration.
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To analyze the possible effects of BMI, an interaction
term between a two-category BMI variable (overweight
and obese) and PM exposure was added in the multivari-
able regression model. Using the same two BMI categor-
ies, stratified linear regression models (adjusted for age,
sex, smoking status, and apparent temperature) were run.
Given the results of the previous step, we used multi-
variable linear regression models to verify the association
between PM10 exposure on the day before recruitment
(Day −1–PM10) and miRNA expression in the screening
and validation phases. MiRNA expression values were
log2-transformed to achieve a normal distribution. Due
to the high number of comparisons, we applied a multiple
comparison correction method based on the Benjamini-
Hochberg False Discovery Rate (FDR) to calculate the
FDR P-value. In the screening phase, the criterion used to
identify the top miRNAs was a FDR P-value <0.10 for
miRNAs expressed in at least 50% of subjects. In the valid-
ation phase, miRNAs with raw P < 0.05 were considered
differentially expressed. A volcano plot of Δ% vs. log10
P-values was used to display results of the screening
and validation analyses.
Multivariable linear regression models were used to
test the association between Day −1–PM10 exposure and
fibrinogen levels (naturally log-transformed to approxi-
mate normality of residuals), which we hypothesized
could be mediated through changes in miRNA expres-
sion. Each validated miRNA was separately considered
as a potential mediator (M) in a simple mediation
model. Two multivariable linear regression models were
used for the association between (Eq. 1) PM10 exposure
and M, and (Eq. 2) M and outcome/fibrinogen concen-
tration (Y) [26, 27]:
Mi ¼ β0 þ β1X1i þ⋯þ βpXpi þ βPM10PM10i þ εi:
ð1Þ
Y i ¼ γ0 þ γ1X1i þ⋯þ γpXpi þ γPM10PM10i
þ γMMi þ εi: ð2Þ
In these models, γPM10 is the estimate of the direct ef-
fect, and the product βPM10
∗ γM is the estimate of the indir-
ect (mediated) effect. Bias-corrected bootstrap confidence
intervals were provided, with the number of bootstrap
samples equal to 10,000 [28]. Estimates correspond to
10 μg/m3 increase in PM10 concentration.
All statistical analyses were performed by using SAS
9.4 statistical software (SAS Institute Inc., Cary, NC) and
STATA 13 (StataCorp. 2013, College Station, TX). Sim-
ple mediation analyses were executed on the SAS v9.4
macro, using the PROCESS program (model = 4) pro-
vided by Hayes (2013) [26].
miRNA targets related to CVD and biological network
analysis
To elucidate the possible biological mechanisms con-
necting EVs-miRNA content and the predisposition to
CVD we performed an integrated network analysis. Dis-
GeNET database (v4.0) [29] was used as source for the
CVD related genes network: we manually selected among
the diseases containing at least 20 associated genes (only
expert-curated associations were evaluated) those related
to CVD. Namely we considered: Myocardial Ischemia,
Hypertensive Diseases, Inflammation, Heart Failure,
Myocardial Infarction, Asthma, Thrombosis, Heart
Diseases, Cardiovascular Diseases, Ischemia, Cerebral
Hemorrhage, Atrial Fibrillation, Coronary Heart Dis-
ease, Cardiac Arrhythmia and their related genes. Next
we built a miRNA-target interaction network containing
the genes whose 3’UTR was predicted to interact with
each of the miRNAs differentially expressed in response
to PM. We considered as bona-fide miRNA-target interac-
tions only those predicted by at least 2 algorithms among
DIANA-microTv4.0, miRanda-rel2010, PicTar2, PITA,
RNA22v2 and Targetscan6.2 (in the version provided by
mirWalk 2.0 database) [30]. Integrating these two net-
works we identified significantly enriched EV-miRNAs
(FDR < 0.1, Fisher test) among targets of specific CVDs
and hub genes related to multiple CVDs and putatively af-
fected by EVs-miRNAs alteration as relevant elements of
the miRNA mediated risk of CVD.
Finally, given the correlation of five EV-miRNAs expres-
sion with fibrinogen levels, we integrated the miRNA-
target subnetwork relative to these five miRNAs with the
genes involved in the coagulation cascade according to
KEGG, to identify the putative effectors of miRNA
alteration.
Network integration and the relative images were elab-
orated with Cytoscape V3.4 [31].
Results
Characteristics and PM10 exposure of study participants
The study population included 1630 subjects (26.9% men,
73.1% women), with the first (discovery) and second
(validation) stages of the study involving 883 and 747
consecutively recruited subjects, respectively. Main
characteristics of the study subjects are reported in
Table 1. The mean age of patients was 52.4 years. Par-
ticipants were categorized according to their BMI as
being overweight (26.9%; BMI: ≥25 to <30 kg/m2),
obese (38.7%; BMI: ≥30 to <35 kg/m2), or severely
obese (34.4%; BMI: ≥35 kg/m2). Nearly half of partici-
pants (48.7%) were never smokers, 35.3% were former
smokers, and 15.8% were current smokers. Most partic-
ipants (60.6%) were enrolled during the autumn and
winter seasons, and most lived in the Milan city area
(59.8%). The median fibrinogen concentration was
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325 mg/dl. Screening and validation subsets were slightly
different in terms of subject’s age, season of enrolment
distribution and fibrinogen concentration (Table 1).
The PM10 exposure during each time lag is reported in
Additional file 4. The highest values measured in the
discovery phase most likely resemble the PM10 time
trend. All values measured in the discovery phase were
higher than values measured in the validation phase
(P < 0.0001).
Association between ambient PM10 levels and EV
quantification by NTA
To define the PM10 exposure window that was most ef-
fective in modifying EV release, we investigated the
association between different time lags and EV count by
NTA. The mean plasma EV was 207.5 nm, and the
mode was 148.5 nm. A histogram showing the size dis-
tribution across samples is reported in Additional file 5.
EV count by NTA descriptive statistics are reported in
Additional file 6.
The positive effect of PM10 exposure on EV count was
maximal on the day before recruitment (Day −1, Fig. 1a).
On Day −1, for each 10-μg/m3 increase in PM10 concen-
tration, we observed an increase in EV count (Δ% = 3.5%,
P = 0.0001). Figure 1b reports the association between
PM10 exposure on Day −1 and the number of EVs mea-
sured by NTA. Given this result, we focused all further
analysis on Day −1. As we also considered long-term
Table 1 Characteristics of study participants
Characteristic Total population Discovery subset Validation subset P
N = 1630 n = 883 n = 747
Sex
Males 438 (26.9%) 237 (26.8%) 201 (26.9%) 0.9756
Females 1192 (73.1%) 646 (73.2%) 546 (73.1%)
Age, years (mean ± SD) 52.4 ± 13.8 51.5 ± 13.5 53.5 ± 14.1 0.0050
BMI*, kg/m2 (mean ± SD) 33.6 ± 5.4 33.7 ± 5.6 33.5 ± 5.3 0.4758
BMI* categorical
Overweight (25–30 kg/m2) 438 (26.9%) 238 (27.0%) 200 (26.8%) 0.7290
Obese (≥30 kg/m2) 1191 (73.0%) 645 (73.0%) 546 (73.1%)
Missing 1 (0.1%) _ 1 (0.1%)
Smoking status
Never smoker 794 (48.7%) 447 (50.6%) 347 (46.5%) 0.3425
Former smoker 575 (35.3%) 303 (34.3%) 272 (36.4%)
Current smoker 258 (15.8%) 131 (14.8%) 127 (17%)
Missing 3 (0.2%) 2 (0.2%) 1 (0.1%)
Year of enrollment
2010 90 (5.5%) 90 (10.2%) _ _
2011 409 (25.1%) 409 (46.3%) _
2012 384 (23.6%) 384 (43.5%) _
2013 304 (18.7%) _ 304 (40.7%)
2014 324 (19.9%) _ 324 (43.4%)
2015 119 (7.3%) _ 119 (15.9%)
Season of enrollment
Winter 487 (29.9%) 223 (25.3%) 264 (35.3%) < 0.0001
Spring 430 (26.4%) 227 (25.7%) 203 (27.2%)
Summer 213 (13.1%) 106 (12%) 107 (14.3%)
Autumn 500 (30.7%) 327 (37%) 173 (23.2%)
Living area
City of Milan 975 (59.8%) 493 (55.8%) 482 (64.5%) 0.0004
Outside Milan 655 (40.2%) 390 (44.2%) 265 (35.5%)
Fibrinogen, mg/dl (median [Q1-Q3]) 325 [290–366] 328 [295–368] 322 [281–365] 0.0056
*BMI = Body mass index
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exposures (i.e. 6-months and yearly averages), we observed
a negative significant association between PM10 yearly
average and EV count (Δ% = −41.25%, P < 0.0001).
Association between ambient PM10 levels and EV
characterization by flow cytometry
According to our hypothesis, we chose a panel of EV
markers that are characteristic of EV-releasing cells and
possibly related to PM10 effects. We characterized five
EV types (Additional file 6): CD61+ EVs (released from
platelets), CD66+ EVs (released from neutrophils),
EpCAM+ EVs (released from epithelial cells), CD105+
EVs (released from endothelium), and CD14+ EVs (re-
leased from monocytes). Table 2 reports the associations
between Day −1–PM10 exposure and EV types released.
A positive association was observed between PM10 and
CD61+ EVs (Δ% = 5.27%, P = 0.0020), EpCAM+ EVs
(Δ% = 2.97%, P = 0.0430), and CD14+ EVs (Δ% = 4.68%,
P = 0.0030).
Overweight subjects showed a greater effect of PM
exposure in all cellular subtypes, whereas for obese
subjects, the effect was significant only for CD61+ EVs
(Δ% = 4.65%, P = 0.0195; Table 3).
Association between ambient PM10 levels and EV-miRNAs
Profiling
To assess the occurrence of a signature EV-miRNA re-
sponse to ambient PM10, we used OpenArray technology
to screen for EV-miRNA expression among 883 con-
secutive subjects. After data cleaning (see Additional file 2-
Supplemental Methods S3), we examined 545 miRNAs for
their association with Day −1–PM10 exposure values using
multivariable analysis adjusted for age, sex, BMI, smoking
status, and apparent temperature. We identified 146
miRNAs that were altered (typically downregulated) in
response to Day −1–PM10 exposure (Fig. 2).
After FDR adjustment for multiple comparisons (FDR
P < 0.1), 46 miRNAs were significantly associated with
the Day −1–PM10 exposure (Additional file 7). The pre-
sented results were normalized by the global mean miRNA
expression.
As a sensitivity analysis, we applied additional methods
for normalization (four more stable miRNAs, U6). This
step did not significantly affect our findings. We repeated
the analysis of the association between miRNAs and Day
−1–PM10 by considering exposure estimates from the
ARPA CTM (see Methods). This method is characterized
by a better spatial resolution than the monitoring stations,
but was available only for subjects involved in the screen-
ing step. This ancillary analysis did not change our main
findings.
Validation
Among the miRNAs that were expressed in at least 50%
of subjects in the screening subset, we validated the ex-
pression of the top 40 differentially expressed miRNAs
in 747 consecutive subjects (Additional file 8), using an
OpenArray custom panel. Nine of the candidate miRNAs
were negatively associated with Day −1–PM10 exposure in
the validation set (Table 4). Each 10-μg/m3 increase in
Fig. 1 a Association of PM10 levels measured at different time lags (from day of blood drawing to the previous 7 days) with EV count by NTA.
Δ% = (exp (β)-1)*100. b Association of individual Day −1–PM10 exposure with number of EVs measured by NTA. Models reported in both panels
were adjusted for age, sex, BMI, smoking status, and apparent temperature
Table 2 Flow cytometry analysis of the association between
PM10 exposure (Day −1) and cell-specific EV count, after
adjustments for age, sex, BMI, smoking status, and apparent
temperature
EV type Δ%a 95% CI P
CD61+ (platelets) 5.27 1.91; 8.73 0.0020
CD66+ (neutrophils) 1.94 −0.59; 4.54 0.1351
EpCAM+ (epithelium) 2.97 0.10; 5.93 0.0430
CD105+ (endothelium) 2.05 −0.22; 4.38 0.0776
CD14+ (macrophages/monocytes) 4.68 1.58; 7.87 0.0030
aΔ% = (exp (β*10)-1)*100, percentage increase in EV count for each 10-μg/m3
increase in PM10 concentration
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PM10 concentration was associated with a 4.2% decrease
in hsa-miR-218-5p expression and a 3.51% decrease in
hsa-miR-642-5p expression. The remaining seven miRNAs
(hsa-miR-99b-5p, hsa-let-7c-5p, hsa-miR-331-3p, hsa-miR-
185-5p, hsa-miR-106a-5p, hsa-miR-143-3p, and hsa-miR-
652-3p) had decreases in expression ranging from 2.59% to
3.14% (Table 4).
Functional analysis of validated miRNAs
To elucidate the mechanisms through which the nine
validated EV-miRNAs could mediate the increase of
CVD risk produced by PM10 exposure, we built and ana-
lyzed their miRNA-target prediction networks. For each
of the nine miRNAs (hsa-let-7c-5p, hsa-miR-106a-5p,
hsa-miR-143-3p, hsa-miR-185-5p, hsa-miR-218-5p, hsa-
miR-331-3p, hsa-miR-642-5p, hsa-miR-652-3p, and hsa-
miR-99b-5p), we considered miRNAs predicted by at
least two of the six evaluated prediction algorithms to be
bona fide target genes. In this way, we obtained a net-
work of nine miRNAs and 14,089 predicted target genes.
To identify the targets involved in cardiac pathologies,
we selected expert-curated gene associations of the main
CVDs from the DisGeNET database (v4.0), thereby
obtaining a network with 741 genes. The integration of
these two networks highlighted the presence of 561
CVD-related genes that were the predicted targets of at
least one EV-miRNA (Additional file 9).
All of the EV-miRNAs were enriched in targets among
the whole list of CVD-related genes with respect to the
database (FDR < 0.1, Fisher test), whereas only some
EV-miRNAs were significantly enriched among the tar-
gets of specific CVDs (FDR < 0.1, Fisher test, Fig. 3).
Hsa-miR-99b-5p was not enriched in targets in any of
the selected pathologies. Four miRNAs, hsa-miR-106a-
5p, hsa-miR-143-3p, hsa-miR-185-5p, and hsa-miR-642-
3p, were enriched in targets among genes related to
asthma, inflammation, MI, and hypertensive disease.
Figure 3 (center) reports the results of network analysis
showing genes involved in at least four pathologies.
Among them, BLC2 and PTGS2 (COX2) were the puta-
tive targets of six or more EV-miRNAs and, therefore,
could be the most relevant mediators for the effects of
EV-miRNAs on the CV system.
Table 3 Flow cytometry analysis of association between PM10 exposure (Day −1) and cell-specific EV count, after BMI stratification
and adjustment for age, sex, smoking status, and apparent temperature
Overweight (25 ≤ BMI < 30 kg/m2) Obese (BMI ≥ 30 kg/m2) P for Interaction
EV type Δ%a 95% CI P Δ% 95% CI P
CD61+ (platelets) 7.58 0.96; 14.62 0.0249 4.65 0.74; 8.70 0.0195 0.4531
CD66+ (neutrophils) 5.48 0.68; 10.51 0.0257 0.53 −2.45; 3.60 0.7305 0.0881
EpCAM+ (epithelium) 8.11 2.22; 14.34 0.0068 0.93 −2.34; 4.31 0.5833 0.0263
CD105+ (endothelium) 5.09 0.51; 9.88 0.0298 0.70 −1.91; 3.38 0.6012 0.0826
CD14+ (macrophages/monocytes) 12.04 5.93; 18.51 0.0001 1.51 −2.05; 5.19 0.4119 0.0032
aΔ% = (exp (β*10)-1)*100, percentage increase in EV count for each 10-μg/m3 increase in PM10 concentration
Fig. 2 Volcano plot reporting univariate association of Day −1–PM10
exposure and all measured miRNAs in EVs. Red dots represent miRNAs
chosen for validation. Gray dots represent miRNAs expressed in <50%
of subjects. Black dots represent miRNAs with P < 0.05 that were
expressed in ≥50% of subjects
Table 4 Association between PM10 exposure (Day −1) and
levels of validated miRNAs in EVs, after adjustment for age, sex,
BMI, smoking status, and apparent temperature
miRNA name Δ%a 95% CI P
hsa-miR-218-5p −4.20 −1.87; −6.47 0.0005
hsa-miR-99b-5p −3.14 −0.56; −5.65 0.0173
hsa-let-7c-5p −2.72 −0.31; −5.08 0.0270
hsa-miR-331-3p −3.07 −0.26; −5.80 0.0328
hsa-miR-185-5p −2.78 −0.19; −5.31 0.0359
hsa-miR-642-5p −3.51 −0.17; −6.74 0.0397
hsa-miR-106a-5p −2.59 [−0.11; −5.01] 0.0409
hsa-miR-143-3p −2.75 [−0.04; −5.39] 0.0467
hsa-miR-652-3p −2.69 [−0.03; −5.29] 0.0478
aΔ% = (2 (β*10)-1)*100, percentage increase in EV count for each 10 μg/m3
increase in PM10 concentration
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Mediation analysis of the influence of PM10 exposure on
coagulation
A 10-μg/m3 increase in Day −1–PM10 exposure was as-
sociated with an average increase in fibrinogen concen-
tration of 1.16% (P < 0.001). We performed a mediation
analysis to estimate the extent to which the nine validated
miRNAs mediated the effects of Day −1–PM10 exposure
on fibrinogen levels. Mediation analysis suggested that the
association between fibrinogen levels and Day −1–PM10
exposure may be mediated by five of the nine miRNAs:
hsa-let-7c-5p, hsa-miR-331-3p, hsa-miR-185-5p, hsa-miR-
106a-5p, and hsa-miR-652-3p (Fig. 4a).
Guided by these measurements, we integrated the in-
formation contained in the EV-miRNA target network
with the coagulation cascade described in KEGG
(Fig. 4b). We found that 27 of the 36 genes included in
this cascade could be putative targets of at least one of the
five miRNAs whose expression is down-modulated after
PM exposure and correlates with fibrinogen increase. In
particular, F10 is predicted to be the target of miR-331-3p,
whereas PAI is targeted by hsa-let-7c-5p, hsa-miR-331-3p,
hsa-miR-185-5p, and hsa-miR-106a-5p. Overall, the path-
way seems to be tightly controlled by these miRNAs.
Moreover, fibrinogen itself was a predicted target of hsa-
miR-106a-5p on its beta chain and hsa-miR-185-5p on its
alpha chain.
Discussion
In the present study, we show that short-term exposure
to PM10 is associated with an increased release of EVs in
a population of overweight/obese subjects [20]. This ef-
fect was mainly due to EVs derived from monocyte/
macrophage components (CD14+) and from platelets
(CD61+). EV miRNA content was examined, and we
identified a nine-miRNA signature that was downregu-
lated in response to PM10 exposure. Results of an inte-
grated network analysis highlighted the putative role of
these miRNAs in CVD. PM10 exposure was also signifi-
cantly associated with elevated fibrinogen levels. Through
mediation analysis, we identified five of the nine miRNAs
as mediators between PM exposure and fibrinogen levels.
Our findings support the hypothesis that EVs play an im-
portant role in mediating the health effects of PM expos-
ure, possibly through their miRNA cargo, providing a
powerful tool of intercellular communication at the pul-
monary and systemic levels.
Cells continuously release EVs, including both exo-
somes and microvesicles, through which the cells
Fig. 3 Functional analysis of validated miRNAs. Disease nodes are represented as squares. Bar graph indicates the percentage of predicted targets
for each of the nine EV-miRNAs among genes connected to the disease. Rounded nodes show genes involved in at least four pathologies. Increasing
blue tone reflects an increase in the number of EV-miRNAs predicted to target each gene. * Significantly enriched EV-miRNAs (FDR < 0.1, Fisher test)
among targets of specific CVDs
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transfer their protein and RNA contents. This process rep-
resents an important mechanism for cell-to-cell communi-
cation [10]. Exosomes are thought to be constitutively
generated, stored, and released from the endosomal system,
whereas microvesicles are shed from the plasma membrane
in response to specific stimuli, [32] such as PM exposure.
Our investigation focused on EV trafficking and re-
lated outcomes in a very large group of overweight or
obese subjects. Increased BMI has been reported to
cause chronic low-grade inflammation [33]. Surprisingly,
the association between PM10 exposure and the release
of endothelial EVs (as well as most other EV types) was
limited to overweight subjects (BMI < 30). Only platelet
EVs maintained their association with PM10 in obese sub-
jects. These findings are consistent with our preliminary
investigation in 25 normal-weight subjects (BMI < 25) and
25 overweight subjects (25 ≤ BMI < 30) who were exposed
to PM10 and PM2.5. The effect of PM exposure on EV re-
lease was visible in overweight subjects only [34] and was
mainly focused on EV of endothelial origin (CD105+).
As studies of EVs are still in their infancy, it is impos-
sible to draw any definitive conclusion on this complex
relationship between PM exposure, EVs, and BMI. One
possible scenario is that normal-weight subjects show a
low reactivity to PM exposure, as shown in our previous
work [34], whereas overweight subjects acquire higher
reactivity to PM. All of the EV types investigated are
positively modulated by PM exposure, which is suggest-
ive of a complex interplay and cross-talk between differ-
ent cell types. As BMI further increases, only platelet
EVs respond to PM exposure, possibly generating a hy-
percoagulability status, which is no longer balanced by
an efficient response from other cell types. This specula-
tion needs to be further investigated to understand why
subjects with increasing BMI behave differently.
In addition to the positive short-term PM10 exposure
effects we described, we also observed a negative long-
term effect of the yearly average of PM10 exposure. This
negative effect is suggestive of an adaptation of EV re-
sponse, as the total number of EVs is lower in those sub-
jects who had an higher chronic (i.e. 1 year average)
exposure.
To the best of our knowledge, only one study previ-
ously reported the effects of PM exposure on EV-
packaged miRNAs, in 22 elderly residents of the Boston
area [35]. Rodosthenous and colleagues found an associ-
ation between long-term ambient PM2.5 levels and in-
creased levels of EV-miRNAs circulating in serum. Our
study complements and supports this first evidence, inves-
tigating the role of short-term exposure and finding an
overall increase in EV count in response to PM exposure.
We identified nine miRNAs that were downregulated
in response to PM10 exposure, five of which (let-7c,
miR-331, miR-185, miR-106a, and miR-652) had a medi-
ator role in the association between PM exposure and
increased fibrinogen levels. Some of these miRNAs have
previously been reported to have specific roles in CV
processes and diseases [36–42]. In particular, miR-185
may serve as a key regulator of lipid metabolism by tar-
geting the hepatic scavenger receptor class B type I,
which plays an important role in selective high-density
lipoprotein cholesterol uptake reversing cholesterol
transport [36]. MiR-185 is also a posttranscriptional
regulator of low-density lipoprotein receptor (LDLR),
Fig. 4 Influence of PM10 exposure on coagulation. a Investigation of whether the five validated miRNAs mediate the association between PM10
concentration (y-axis) and fibrinogen level (x-axis). β, coefficient of the independent variable when regressing the mediator on the independent
variable; γ, coefficient of the mediator when regressing the dependent variable on both the independent variable and the mediator. An indirect
effect (IE) represents the “mediated effect” through the five validated miRNAs. Estimates correspond to 10-μg/m3 increase in PM10 concentration.
Results from regression models were adjusted for age, sex, BMI, smoking status, and apparent temperature. b Coagulation cascade. For each gene
reported in the pathway, the possible regulatory role of each miRNA is reported
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which mediates endocytosis of LDL particles and helps
maintain plasma cholesterol levels [37]. Together with
the observed decreased expression of miR-106a, down-
regulation of miR-106a was found to predict the future
risk of fatal MI in healthy individuals [38]. Low serum
levels of miR-106a were also reported in patients with
acute heart failure [39]. MiR-331 was previously found
to regulate the expression of both fibrinogen receptor
subunits (αIIb and β3) in platelets [40]. Given that we ob-
served a considerable decrease in miR-331 levels, we
could speculate that this process might result in en-
hanced sensitivity to fibrinogen, which, in turn, might
determine increased platelet reactivity and play an im-
portant role in the hemostatic and thrombotic functions
of platelets. The miRNA expression patterns in platelets
influence their reactivity, impacting blood coagulation
[41]. MiR-218 was shown previously to downregulate fi-
brinogen synthesis [42]; therefore, the lower levels of ex-
pression that we observed in response to PM exposure
might partly explain the increased fibrinogen concentra-
tion. However, this finding was not supported by the re-
sults of our mediation analysis.
This study has several strengths, including a large
sample size and careful attention to methodological is-
sues, including all of the steps from sample collection to
biomarker measurements. EV analysis itself is very chal-
lenging. In the past decade, increasing numbers of re-
searchers have begun investigating EVs; however, those
studies have had many limitations related to small sam-
ple size, the technical challenges of measuring and char-
acterizing EVs, and the risk of contamination by other
nonvesicular entities (e.g., protein complexes). The
International Society for Extracellular Vesicles (ISEV) re-
cently published the minimal technical requirements
that should be used in EV isolation [43] and biochem-
ical, biophysical, and functional studies [44]. The present
study, which includes the largest study population to
date, takes all of the ISEV technical requirements into
account [43, 44]. NTA and flow cytometry analyses were
performed on fresh blood, to avoid hemolysis of the
sample and to limit EV modifications [45].
The two exposure assessment methods applied to per-
form miRNA discovery (monitoring stations vs. CTM)
yielded very similar results. This result indicates that
neither the potential measurement error of the monitor-
ing stations nor the uncertainty of the CTM estimates
consistently contributed to our results. Thus, we are
confident that the association we identified between
PM10 and miRNAs was independent of the selected ex-
posure assessment method.
We used the OpenArray technology, a relatively new
method combining the precision of real-time quantitative
PCR (RT-qPCR) with the high throughput of microarray
analysis. A recent study compared the reproducibility,
specificity, sensitivity, and accuracy of the different avail-
able methods for miRNA analysis (hybridization methods,
RT-qPCR, and miRNAseq), across 12 platforms from nine
different vendors [46]. That study found higher overall de-
tection rates and better sensitivity for RT-qPCR versus
hybridization platforms. Our use of a screening set of
samples and an independent set of validation samples
lowered the possibility that our findings were due to
chance.
Although normalization is often advocated as a critical
step in miRNA analysis, especially when a fixed volume
of sample rather than a fixed quantity of RNA is man-
aged, there is no general consensus for the best method
of normalization [47]. To address this problem, we applied
multiple strategies of normalization in the discovery ana-
lysis (global mean, RNU48, RNU6, and the average of the
four miRNAs with the lowest SD among subjects), which
gave very consistent results. We report in detail the results
obtained by global mean normalization [48], because the
global mean exhibited a more stable expression pattern
according to geNorm and NormFinder. As the global
mean approach was intrinsically not suitable for validation
analysis, we applied an alternative normalization strategy,
combining an endogenous (RNU6) and an exogenous
(ath-miR159a) control miRNA, as suggested by Schwar-
zenbach and colleagues [49]. According to the authors,
this approach compensates for each difference in miRNA
recovery, cDNA synthesis, and quality of samples.
The present study has some limitations. First, although
we were able to characterize EV origin by flow cytome-
try, no reliable technical procedure is available to separ-
ate EVs produced by different cell types, limiting the
study of miRNAs in EVs as a whole. Second, in the dis-
covery step, 349 miRNAs were associated with PM10 ex-
posure. We had to perform a selection process to
validate only 40 of them based on statistical criteria. This
procedure might have prevented us from identifying
other relevant miRNAs related to PM10 exposure and
coagulation. Third, we used PM10 instead of PM2.5 as
the air pollutant of choice because the PM10 dataset was
more complete and characterized by a better spatial
resolution. However, in the study area, PM10 is mainly
constituted by fine particles, and PM2.5 represents 58–
94% of PM10 [50]. Another possible constraint is the lack
of personal exposure monitoring, due to the large study
sample. This limitation also hampered the possibility of
accounting for indoor air pollution [51]. Nonetheless, in
the abovementioned paper by Bonzini et al., we com-
pared PM10 and PM2.5 levels measured by ambient mon-
itoring stations with those measured through personal
samplers in 51 healthy volunteers, and found the two
measures to be significantly correlated (r = 0.59,
P < 0.001). Furthermore, the two pollutants showed a
highly significant correlation (r = 0.97; P < 0.001) [34].
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Unfortunately, no repeated measurements have been
obtained, which might have been preferential to study
acute changes.
Conclusions
In conclusion, research on EVs opens a new path to the
investigation of the adverse health effects of air pollution
exposure. EVs have the potential to act both as markers
of PM susceptibility and as potential molecular mechan-
ism in the chain of events connecting PM exposure to
increased coagulation, which is frequently linked to ex-
posure and CVD development.
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